Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company’s lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Anebulo Pharmaceuticals, Inc.
OTC:ANEBHealthcare · Biotechnology
-5.17%$0.2750
Mkt Cap$11.22M
Float7.26M
O/S40.78M
Inst Own1.1%
SI5.4%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$8.48M
Total Assets$12.15M
Free Cash Flow-$6.35M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$11.66M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ANEB's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$12.15M
Liabilities$488K
Accounts Receivable$73K
Accounts Payable$224K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $4.3M | $3.55M | $5.6M | $2.96M | $2.27M | $150K |
| Selling, General, and Administrative | $4.92M | $4.76M | $6.18M | $3.87M | $1.34M | $23K |
| Other | $0 | $0 | $0 | $0 | -$1K | $0 |
| Total Operating Expenses | $9.22M | $8.31M | $11.78M | $6.83M | $3.61M | $173K |
| Operating Income (EBIT) | -$9.22M | -$8.31M | -$11.78M | -$6.83M | -$3.61M | -$173K |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $382K | $151K | $0 | $0 | $12K | $1K |
| Interest Income | $258K | $249K | $92K | $7K | $1K | $0 |
| Other Income (Expense) | $739K | $107K | $51K | $6K | -$26.64M | -$1K |
| Income Before Tax (EBT) | -$8.48M | -$8.2M | -$11.73M | -$6.83M | -$30.25M | -$175K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8.48M | -$8.2M | -$11.73M | -$6.83M | -$30.25M | -$175K |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -0.25 | -0.32 | -0.47 | -0.29 | -1.30 | -0.01 |
| Diluted EPS | -0.25 | -0.32 | -0.47 | -0.29 | -1.30 | -0.01 |
| Weighted Average OS | 33.82M | 25.82M | 25.07M | 23.34M | 23.34M | 23.72M |
| EBITDA | -$7.72M | -$7.9M | -$11.73M | -$6.83M | -$30.24M | -$173K |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $11.63M | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $11.63M | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M |
| Accounts Receivable | $73K | $0 | $0 | $0 | $0 | $4K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | -$0 | $0 | -$0 | $0 |
| Total Current Assets | $11.96M | $3.51M | $11.67M | $15.58M | $21.65M | $3.03M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $183K | $565K | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $183K | $565K | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $12.15M | $4.07M | $11.67M | $15.58M | $21.65M | $3.03M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $224K | $156K | $535K | $381K | $110K | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $201K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$264K | $0 | -$0 | $0 | -$0 | $23K |
| Total Current Liabilities | $224K | $261K | $1.07M | $513K | $242K | $224K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $264K | $0 | -$0 | $0 | -$0 | $0 |
| Total Long-Term Liabilities | $264K | $0 | -$0 | $0 | -$0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $488K | $261K | $1.07M | $513K | $242K | $224K |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $2.98M |
| Common Stock | $41K | $26K | $26K | $23K | $23K | $12K |
| Retained Earnings | -$73.89M | -$65.4M | -$57.2M | -$45.47M | -$38.64M | -$183K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | -$0 | $0 |
| Other Stockholders' Equity | $85.51M | $69.19M | $67.78M | $60.51M | $60.03M | $2.98M |
| Total Equity | $11.66M | $3.81M | $10.6M | $15.07M | $21.41M | $2.8M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $12.15M | $4.07M | $11.67M | $15.58M | $21.65M | $3.03M |
| Supplementary Data | ||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $201K |
| Net Debt | -$11.63M | -$3.09M | -$11.25M | -$14.55M | -$19.99M | -$2.82M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Operating Activities | ||||||
| Net Income | -$8.48M | -$8.2M | -$11.73M | -$6.83M | -$30.25M | -$175K |
| Depreciation & Amortization | $382K | $151K | $0 | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $1.45M | $759K | $885K | $481K | $200K | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$73K | $0 | $0 | $0 | $4K | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$4K | $0 |
| Accounts Payable | $68K | -$378K | $154K | $271K | $110K | $0 |
| Other Working Capital | $312K | -$421K | $1.01M | $637K | -$1.56M | $23K |
| Total Working Capital Change | $306K | -$799K | $1.16M | $908K | -$1.45M | $23K |
| Other Non-Cash Items | $0 | $0 | $0 | $0 | $26.63M | $1K |
| Net Cash from Operating | -$6.35M | -$8.09M | -$9.68M | -$5.44M | -$4.87M | -$151K |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | - | - | - | $201K | - |
| Common Stock Issuance | $14.88M | -$62K | $6.65M | $0 | $22.85M | $2.98M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$265K | $0 | -$822K | $0 |
| Net Cash from Financing | $14.88M | -$62K | $6.38M | $0 | $21.83M | $3.18M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $8.53M | -$8.15M | -$3.3M | -$5.44M | $16.96M | $3.02M |
| Supplementary Data | ||||||
| Operating Cash Flow | -$6.35M | -$8.09M | -$9.68M | -$5.44M | -$4.87M | -$151K |
| Capital Expenditure | -$3 | -$1 | $0 | $4 | $0 | $2 |
| Free Cash Flow | -$6.35M | -$8.09M | -$9.68M | -$5.44M | -$4.87M | -$151K |
| Cash at Beginning | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M | $0 |
| Cash at End | $11.63M | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M |